| 名稱 | G007-LK |
| 描述 | G007-LK is a selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and 25 nM, respectively. |
| 細胞實驗 | Cell lines: APC-mutant CRC cell lines COLO-320DM. Concentrations: ~0.2 μM. Method: For colony formation assays,cells are seeded at 500 cells/well in 2 mL medium.Cell line in triplicate wells is treated with either 0.06% DMSO or compound in 0.06% DMSO and incubated for up to 17 days or until colonies became sufficiently large to quantify.Colonies are stained with 200 μL of 12 mM 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to each well for 1 h,and colony numbers are quantitated with a GelCount scanner at 1200 dpi resolution. |
| 激酶實驗 | TNKS1 and TNKS2 in vitro biochemical assays: G007-LK inhibitory activity at various doses (duplicates) is tested twice by TNKS1, TNSK2 Chemiluminescent Assay Kits, and the luminescence is measured. |
| 動物實驗 | Animal Models: Human APC –mutant CRC xenograft COLO-320DM. Formulation: 15% DMSO,17.5% Cremophor EL,8.75% ethanol,8.75% Miglyol 810N,50% PBS. Dosages: 20 mg/kg. Administration: intraperitoneal injection twice daily |
| 體外活性 | G007-LK在異種移植和基因工程CRC模型中顯示出抗腫瘤效力.在COLO-320DM模型中,G007-LK降低了tankyrases 1和tankyrases 2蛋白水平,穩(wěn)定了AXIN1和AXIN2,并降低了β-catenin水平.G007-LK治療增加COLO-320DM腫瘤中KRT20和TM4SF4的表達. G007-LK（20 mg/kg每日兩次）達到61％的腫瘤生長抑制.G007-LK降低正常腸道中的Wnt/β-連環(huán)蛋白信號傳導和細胞增殖. |
| 體內活性 | G007-LK通過防止多聚（ADP-核糖基）依賴性的AXIN降解來降低Wnt /β-連環(huán)蛋白信號傳導,由此促進β-連環(huán)蛋白去穩(wěn)定化。G007-LK在細胞培養(yǎng)中完全阻斷配體驅動的Wnt/β-連環(huán)蛋白信號傳導,并在大多數(shù)CRC細胞系中顯示對約50％APC突變驅動的信號傳導的抑制。 G007-LK（0.2 μM）將有絲分裂中的COLO-320DM細胞數(shù)量從24％降低至12％,并將S期中的HCT-15細胞從28％降低至18％。G007-LK抑制CRC系列COLO-320DM和SW403中的集落形成。 G007-LK抑制器官生長,IC50為80 nM。 |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度 | Ethanol : < 1 mg/mL (insoluble or slightly soluble)
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 93 mg/mL (175.48 mM), Sonication is recommended.
|
| 關鍵字 | βcatenin | Wnt/β-catenin | Wnt/betacatenin | Wnt/b-catenin | Wnt | TNKS2 | TNKS1 | poly ADP ribose polymerase | PARP | Inhibitor | inhibit | G007-LK | G-007-LK | G007LK | G007 LK | beta-catenin | betacatenin | bcatenin |
| 相關產品 | Urea | Bisdemethoxycurcumin | Niraparib | Nefopam hydrochloride | Olaparib | 3-Aminobenzamide | Benzamide | OUL35 | Echinacoside | Methyl Vanillate | CHIR-99021 | Wnt pathway activator 1 |
| 相關庫 | 神經保護化合物庫 | 抑制劑庫 | 抗乳腺癌化合物庫 | 脂代謝化合物庫 | 經典已知活性庫 | 抗癌化合物庫 | 已知活性化合物庫 | 抗結直腸癌化合物庫 | 抗衰老化合物庫 | 細胞骨架化合物庫 | 癌細胞分化化合物庫 | 抗卵巢癌化合物庫 |